A PROMISE FOR A HEALTHIER TOMORROW

Clariostrong500 mgExtended Release F.C. Tablets

Clariostrong
Clariostrong
A newer clarithromycin formulation, ensures high patient’s compliance and tolerability.
Composition:

Each film coated tablet contains: Clarithromycin base 500 mg.

Propertise:

• Clariostrong-XR: is a member of macrolide antibiotic class, used to treat a wide range of bacterial respiratory infections; it exerts its antibacterial action by binding to the 50s ribosomal subunits of susceptible bacteria resulting in inhibition of protein synthesis that leads to stoppage of bacterial growth.

• Clariostrong-XR: is active in vitro against a variety of aerobic and anaerobic gram positive and gram negative bacteria as well as most Mycobacterium avium complex (MAC) bacteria.

• Clariostrong-XR: provides an extended absorption of clarithromycin from the GIT after oral administration relative to an equal total daily dose of immediate release clarithromycin tablets.

• Clariostrong-XR: provides lower and later steady state peak plasma concentrations but equivalent 24 hours AUC's for both clarithromycin and its microbiologically active metabolites. 

Indications:

Clariostrong-XR is recommended as the primary agent for the treatment of disseminated infections due to Mycobacterium avium complex.

• Upper respiratory tract infections (URTIs).

• Lower respiratory tract infections (LRTIs). 

Dosage & Administration:

• One tablet to be taken orally once daily or as directed by the physician.

N.B.: Clariostrong-XR: may be given with or without food.